Petter Bjornstad

7.8k total citations · 3 hit papers
195 papers, 5.0k citations indexed

About

Petter Bjornstad is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Surgery. According to data from OpenAlex, Petter Bjornstad has authored 195 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Endocrinology, Diabetes and Metabolism, 87 papers in Nephrology and 48 papers in Surgery. Recurrent topics in Petter Bjornstad's work include Diabetes Treatment and Management (60 papers), Chronic Kidney Disease and Diabetes (56 papers) and Diabetes Management and Research (41 papers). Petter Bjornstad is often cited by papers focused on Diabetes Treatment and Management (60 papers), Chronic Kidney Disease and Diabetes (56 papers) and Diabetes Management and Research (41 papers). Petter Bjornstad collaborates with scholars based in United States, Canada and Netherlands. Petter Bjornstad's co-authors include David Z.I. Cherney, Richard J. Johnson, David M. Maahs, Kristen J. Nadeau, Yuliya Lytvyn, Daniël H. van Raalte, Janet K. Snell‐Bergeon, Megan M. Kelsey, Julie A. Lovshin and Miguel A. Lanaspa and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Petter Bjornstad

180 papers receiving 5.0k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Age-Related Consequences of Childhood Obesity

2014 337 citations Petter Bjornstad, Kristen J. Nadeau et al. profile →
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure

2017 332 citations Petter Bjornstad, David Z.I. Cherney et al. profile →
Combination therapy for kidney disease in people with diabetes mellitus

2024 45 citations Daniël H. van Raalte, Petter Bjornstad et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petter Bjornstad United States	39	2.1k	1.9k	1.2k	959	708	195	5.0k
Peter Hovind Denmark	37	1.4k 0.7×	1.7k 0.9×	573 0.5×	579 0.6×	1.0k 1.4×	72	4.2k
L. Lee Hamm United States	35	1.2k 0.6×	2.3k 1.2×	658 0.6×	958 1.0×	1.4k 2.0×	83	5.2k
Alper Sönmez Türkiye	41	1.1k 0.5×	1.0k 0.5×	918 0.8×	734 0.8×	1.2k 1.7×	169	4.9k
Janet K. Snell‐Bergeon United States	46	3.3k 1.6×	974 0.5×	2.0k 1.7×	959 1.0×	1.3k 1.9×	223	7.2k
Davide Bolignano Italy	38	766 0.4×	2.8k 1.5×	860 0.7×	970 1.0×	1.0k 1.5×	187	5.9k
Barış Afşar Türkiye	35	591 0.3×	1.9k 1.0×	778 0.7×	746 0.8×	904 1.3×	218	4.5k
Elisabeth R. Mathiesen Denmark	50	3.8k 1.8×	1.4k 0.7×	2.7k 2.3×	896 0.9×	1.7k 2.4×	251	11.1k
Ronan Roussel France	43	2.7k 1.3×	514 0.3×	1.4k 1.2×	1.4k 1.4×	827 1.2×	232	6.0k
Nathan R. Hill United Kingdom	24	844 0.4×	1.5k 0.8×	542 0.5×	572 0.6×	748 1.1×	59	4.2k
Lars Christian Rump Germany	46	2.0k 0.9×	1.3k 0.7×	1.7k 1.4×	1.1k 1.1×	3.1k 4.4×	199	7.5k

Countries citing papers authored by Petter Bjornstad

Since Specialization

Citations

This map shows the geographic impact of Petter Bjornstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petter Bjornstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petter Bjornstad more than expected).

Fields of papers citing papers by Petter Bjornstad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petter Bjornstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petter Bjornstad. The network helps show where Petter Bjornstad may publish in the future.

Co-authorship network of co-authors of Petter Bjornstad

This figure shows the co-authorship network connecting the top 25 collaborators of Petter Bjornstad. A scholar is included among the top collaborators of Petter Bjornstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petter Bjornstad. Petter Bjornstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pyle, Laura, Irene G. M. van Valkengoed, Petter Bjornstad, et al.. (2025). Insulin Sensitivity and Associated Plasma Proteomics During Sex Hormone Therapy. The Journal of Clinical Endocrinology & Metabolism. 111(4). e1070–e1079. 1 indexed citations

Heerspink, Hiddo J.L., Allon N. Friedman, Petter Bjornstad, et al.. (2025). Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes. Journal of the American Society of Nephrology. 36(11). 2190–2200. 4 indexed citations

Baar, Michaël J.B. van, Marcel H.A. Muskiet, Daan J. Touw, et al.. (2025). Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes ( RACELINES ): A randomised, double‐blind trial. Diabetes Obesity and Metabolism. 27(7). 3943–3956.

Jongs, Niels, Peter J. Greasley, Cecilia Karlsson, et al.. (2025). Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial. Diabetes Obesity and Metabolism. 27(8). 4415–4426. 1 indexed citations

Thomas, Philip, Celestin Missikpode, Ashish Verma, et al.. (2025). Association of Pancreas Volume With Adverse Clinical Outcomes. Journal of the American Heart Association. 14(21). e042348–e042348.

Nokoff, Natalie, David Z.I. Cherney, Irene G. M. van Valkengoed, et al.. (2024). Unraveling Sex Differences in Kidney Health and CKD. Clinical Journal of the American Society of Nephrology. 20(2). 301–310. 5 indexed citations

Goodrich, Jesse A., Meda E. Pavkov, Daniël H. van Raalte, et al.. (2024). Glycoprotein Acetyls Associate With Intraglomerular Hemodynamic Dysfunction, Albuminuria, Central Adiposity, and Insulin Resistance in Youth With Type 1 Diabetes. Canadian Journal of Diabetes. 48(4). 244–249.e1. 1 indexed citations

Doke, Tomohito & Petter Bjornstad. (2024). Endothelial–Mesenchymal Transition Switch and Diabetic Kidney Disease. Journal of the American Society of Nephrology. 35(6). 670–672. 1 indexed citations

Bjornstad, Petter, et al.. (2024). Dulaglutide and Glomerular Hyperfiltration, Proteinuria, and Albuminuria in Youth With Type 2 Diabetes: Post Hoc Analysis of the AWARD-PEDS Study. Diabetes Care. 47(9). 1617–1621. 4 indexed citations

10.

Furgeson, Seth B., Allison Shapiro, Petter Bjornstad, et al.. (2024). Assessing Cognition in CKD Using the National Institutes of Health Toolbox. Kidney360. 5(6). 834–840. 4 indexed citations

11.

Antenor, Jo Ann V., Laura Pyle, Vuddhidej Ophascharoensuk, et al.. (2024). Pegloticase-Induced Rapid Uric Acid Lowering and Kidney and Cardiac Health Markers in Youth-Onset Type 2 Diabetes: A Pilot Clinical Trial. Kidney Medicine. 6(12). 100911–100911. 2 indexed citations

12.

Saulnier, Pierre‐Jean & Petter Bjornstad. (2023). Renal hemodynamic changes in patients with type 2 diabetes and their clinical impact. La Presse Médicale. 52(1). 104175–104175. 2 indexed citations

13.

Saulnier, Pierre‐Jean, Helen C. Looker, Anita T. Layton, et al.. (2023). Loss of Glomerular Permselectivity in Type 2 Diabetes Associates With Progression to Kidney Failure. Diabetes. 72(11). 1682–1691. 1 indexed citations

14.

Baar, Michaël J.B. van, Erik J.M. van Bommel, Daan J. Touw, et al.. (2023). Acute Effects of Insulin Infusion on Kidney Hemodynamic Function in People With Type 2 Diabetes and Normal Kidney Function. Kidney International Reports. 8(4). 916–920. 1 indexed citations

15.

Laursen, Jens Christian, Bryan Haddock, Christian Stevns Hansen, et al.. (2022). Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes. Clinical Kidney Journal. 15(11). 2072–2080. 5 indexed citations

16.

Bjornstad, Petter, Laure El ghormli, Kara S. Hughan, et al.. (2021). Effects of Metabolic Factors, Race-Ethnicity, and Sex on the Development of Nephropathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study. Diabetes Care. 45(5). 1056–1064. 11 indexed citations

17.

Velzen, Daan van, Mark M. Smits, Erik J.M. van Bommel, et al.. (2021). Kidney hemodynamic function in men and postmenopausal women with type 2 diabetes and preserved kidney function. American Journal of Physiology-Renal Physiology. 320(6). F1152–F1158. 2 indexed citations

18.

Tonneijck, Lennart, Marcel H.A. Muskiet, Mark M. Smits, et al.. (2018). Effect of immediate and prolonged GLP‐1 receptor agonist administration on uric acid and kidney clearance: Post‐hoc analyses of four clinical trials. Diabetes Obesity and Metabolism. 20(5). 1235–1245. 30 indexed citations

19.

Bjornstad, Petter, Melanie Cree‐Green, Amy Baumgartner, et al.. (2017). Achieving ADA/ISPAD clinical guideline goals is associated with higher insulin sensitivity and cardiopulmonary fitness in adolescents with type 1 diabetes: Results from RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) and Effects of MEtformin on CardiovasculaR Function in AdoLescents with Type 1 Diabetes (EMERALD) Studies. Pediatric Diabetes. 19(3). 436–442. 10 indexed citations

20.

Bjornstad, Petter, David M. Maahs, Franziska K. Bishop, et al.. (2014). Association of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes. Acta Diabetologica. 52(3). 611–619. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact